IL17A and schizophrenia: All in all, our results show that schizophrenia is accompanied by indicants of activation of the M1 (IL-1β, IL-6, TNF-α) and Th17 (IL-17, IL-21, IL-22, and TNF-α) phenotypes and that MNP is additionally characterized by increased IL-6 and IL-23, while increments in those cytokines contribute to increased G-CSF and IL-10 [64–66].